Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres
- 1 December 2005
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 94 (12), 1721-1731
- https://doi.org/10.1111/j.1651-2227.2005.tb01844.x
Abstract
To determine the effectiveness of prenatal treatment for clinical manifestations of congenital toxoplasmosis. We prospectively identified 255 live-born infants with congenital toxoplasmosis using prenatal or neonatal screening. We determined the effect of prenatal treatment on the risks of intracranial or ocular lesions in infancy, accounting for gestational age at maternal seroconversion. Prenatal treatment within 4 wk of seroconversion reduced the risk of intracranial lesions compared with no treatment (odds ratio, OR 0.28; 95% CI: 0.08-0.75), but there was no significant effect when initiated after 4 wk (OR 0.76; 95% CI: 0.35-1.59; overall p-value 0.19). Compared to spiramycin alone, no treatment doubled the risk of intracranial lesions (OR 2.33; 95% CI: 1.04-5.50), but the risk did not differ with pyrimethamine-sulphonamide treatment (overall p-value 0.52). There was no consistent relationship between the type or timing of treatment and the risk of ocular lesions. Gestational age at maternal seroconversion was inversely associated with the risk of intracranial but not ocular lesions. Only early versus no prenatal treatment for intracranial lesions showed a statistically significant benefit. A large randomized controlled trial and/or meta-analysis of individual patient data from cohort studies is required to confirm these findings.Keywords
This publication has 27 references indexed in Scilit:
- Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluidBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birthBJOG: An International Journal of Obstetrics and Gynaecology, 2004
- Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondiiBJOG: An International Journal of Obstetrics and Gynaecology, 2003
- Inference for a linear regression model with an interval‐censored covariateStatistics in Medicine, 2003
- Antitoxoplasma chemotherapyPublished by Cambridge University Press (CUP) ,2001
- Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage DifferentiationExperimental Parasitology, 1999
- Retinochoroiditis is Induced by Oral Administration of Toxoplasma Gondii Cysts in the Hamster ModelExperimental Eye Research, 1999
- Termination of pregnancy for maternal toxoplasmosisThe Lancet, 1994
- Neonatal Serologic Screening and Early Treatment for Congenital Toxoplasma gondii InfectionNew England Journal of Medicine, 1994
- In utero Treatment of Toxoplasmic Fetopathy with the Combination Pyrimethamine-SulfadiazineFetal Diagnosis and Therapy, 1993